Table 3 |
||||||
|
Patient factors associated with permanently switching to oral therapy on follow-up questionnaire |
||||||
|
No. (%) of subjects |
Unadjusted |
Adjusted* |
||||
|
|
||||||
|
Patient factor |
Choosing oral therapy n = 39 |
Choosing injection therapy n = 13 |
OR (95% CI) |
p-value |
OR (95% CI) |
p-value |
|
|
||||||
|
Perceived disadvantages of injections |
||||||
|
Frequent visits to see MD/nurse |
||||||
|
Agree |
27 (96) |
1 (4) |
27.00 |
<0.001 |
35.41 |
0.005 |
|
Disagree |
12 (50) |
12 (50) |
(3.14–231.87) |
(2.90–432.70) |
||
|
Travel/parking costs |
||||||
|
Agree |
23 (92) |
2 (8) |
7.91 |
0.016 |
8.66 |
0.036 |
|
Disagree |
16 (59) |
11 (41) |
(1.54–40.60) |
(1.15–65.30) |
||
|
|
||||||
|
* Adjusted for patient factors at least weakly associated (i.e., p < 0.20) with permanently switching to oral B12 therapy in bivariate analyses: perceived disadvantages of injections (frequent visits to see MD/nurse, travel/parking costs), perceived disadvantage of pills (take too many pills already) |
||||||
|
Kwong et al. BMC Family Practice 2005 6:8 doi:10.1186/1471-2296-6-8 |
||||||
